Compositions and methods useful for the diagnosis and treatment of common variable immunodeficiency are disclosed.
Legal claims defining the scope of protection, as filed with the USPTO.
1. A solid support for detecting at least one common variable immunodeficiency (CVID)-associated copy number variation (CNV) in a sample comprising immobilized nucleic acid probes or primers of 15 or more nucleotides in length, wherein each of said probes or primers present on said solid support specifically hybridize to CVID specific nucleic acids in chromosomal regions consisting of chr11: 85365857-85381622, chr20: 57735790-57741780, chr22: 17396663-18417315, chr4: 10256682-10264316, and chr10: 46003146-46042543, chr2: 148396730-148433180, chr15: 35053039-35063531, chr7: 91789778-91801963, chr2: 163316298-163316595, chr7: 87180702-87191931, and, optionally, one or more of chr19: 9256584-9277749, chr4: 39190766-39201960, chr7: 18903915-18905725, chr5: 170531269-170536993, chr7: 34685030-34686172, and chr1: 170400944-170403742.
2. A kit comprising the solid support of claim 1 and reagents for detecting hybridization of nucleic acids to said solid support.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
August 18, 2015
December 31, 2019
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.